Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

31526
1
Target Group Inc. Target Group Inc. Reports Decline in Revenue and Assets, Raises Concerns About Going Concern

Via official filing (AI summary) | over 1 year ago | 0 comments

31527
1
MACERICH CO Macerich Reports Improved Revenue and Profitability in Q3 2024, Net Income Turnaround

Via official filing (AI summary) | over 1 year ago | 0 comments

31528
1
Doximity, Inc. Doximity Reports 20% Revenue Growth, Strong Operational Performance in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31529
1
StepStone Group Inc. StepStone Group Reports 42% Revenue Growth, Net Income Decline in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31530
1
Skye Bioscience, Inc. Skye Bioscience Reports Significant Financial Developments, Commences Phase 2 Clinical Trial for Lead Drug Candidate

Via official filing (AI summary) | over 1 year ago | 0 comments

31531
1
MCKESSON CORP Mckesson Reports 21% Revenue Growth, Decline in Profitability Amid Increased Expenses and Restructuring Efforts

Via official filing (AI summary) | over 1 year ago | 0 comments

31532
1
MANNKIND CORP MannKind Corporation Reports 37% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31533
1
BRUKER CORP Bruker Corporation Reports 16.4% Revenue Growth, Decline in Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31534
1
Axonics, Inc. Axonics Reports 24.8% Revenue Growth, Narrowed Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31535
1
WK Kellogg Co WK Kellogg Co Reports Mixed Financial Results for Quarter Ended September 28, 2024, Amid Restructuring Efforts

Via official filing (AI summary) | over 1 year ago | 0 comments

31536
1
MetaVia Inc. NeuroBo Pharmaceuticals Reports Significant Changes in Revenue, Expenses, and Financial Health in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31537
1
Gevo, Inc. Gevo Reports 57% Revenue Decline, Net Loss Increase in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31538
1
CEDAR REALTY TRUST, INC. Cedar Realty Trust Reports Decline in Revenues and Profitability in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31539
1
Eventbrite, Inc. Eventbrite Reports Mixed Q3 Results, Net Loss Narrows, Revenue Declines 5%

Via official filing (AI summary) | over 1 year ago | 0 comments

31540
1
aTYR PHARMA INC aTyr Pharma Reports Significant Financial Challenges, No Revenue in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments

31541
1
APPLIED OPTOELECTRONICS, INC. Applied Optoelectronics Reports Mixed Q3 Results with Revenue Growth, Widening Losses

Via official filing (AI summary) | over 1 year ago | 0 comments

31542
1
VYNE Therapeutics Inc. VYNE Therapeutics Reports Modest Revenue Growth, Significant Increase in Operating Expenses and Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31543
1
HeartBeam, Inc. HeartBeam Reports Significant Financial Challenges, Decline in Cash and Cash Equivalents

Via official filing (AI summary) | over 1 year ago | 0 comments

31544
1
Lantern Pharma Inc. Lantern Pharma Reports Significant Decline in Total Assets and Net Losses Amid Rising Operating Expenses

Via official filing (AI summary) | over 1 year ago | 0 comments

31545
1
RIGEL PHARMACEUTICALS INC Rigel Pharmaceuticals Reports Significant Revenue Growth and Profitability Improvement in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31546
1
ALX ONCOLOGY HOLDINGS INC ALX Oncology Reports Improved Financials, Net Loss Reduction, and Strategic Developments in Latest 10-Q Filing

Via official filing (AI summary) | over 1 year ago | 0 comments

31547
1
Goldman Sachs Physical Gold ETF Goldman Sachs Physical Gold ETF Reports Significant Growth in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31548
1
ARKO Corp. ARKO Corp. Reports Decline in Revenue and Profitability for Q3 and Nine Months of 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31549
1
Intapp, Inc. Intapp Reports 17% Revenue Growth, Improved Operating Performance in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

31550
1
COLLEGIUM PHARMACEUTICAL, INC Collegium Pharmaceutical Reports 16.5% Revenue Growth, Net Income Decline in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments